Skip to content
← Back to this collection

PUBLICATIONS · 10852458

Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Endocrinol Metab
Publication date
2000 Jun
First author
Colao A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Colao A
      type
      Author
    2. name
      Di Sarno A
      type
      Author
    3. name
      Landi ML
      type
      Author
    4. name
      Scavuzzo F
      type
      Author
    5. name
      Cappabianca P
      type
      Author
    6. name
      Pivonello R
      type
      Author
    7. name
      Volpe R
      type
      Author
    8. name
      Di Salle F
      type
      Author
    9. name
      Cirillo S
      type
      Author
    10. name
      Annunziato L
      type
      Author
    11. name
      Lombardi G
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Colao A
      type
      Author
    2. name
      Di Sarno A
      type
      Author
    3. name
      Landi ML
      type
      Author
    4. name
      Scavuzzo F
      type
      Author
    5. name
      Cappabianca P
      type
      Author
    6. name
      Pivonello R
      type
      Author
    7. name
      Volpe R
      type
      Author
    8. name
      Di Salle F
      type
      Author
    9. name
      Cirillo S
      type
      Author
    10. name
      Annunziato L
      type
      Author
    11. name
      Lombardi G
      type
      Author
    bibliography ids
    1. nci-bib-e37e98dce6b8b5391b7a85b3
    book metadata
    content sha256
    774cdf9da296530555d24d5f329115d50bc95c6662be09050b7baba9167d5ccb
    document type
    citation
    dois
    1. 10.1210/jcem.85.6.6657
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:10852458
    immutable id
    pubmed:10852458@774cdf9da296530555d24d5f329115d50bc95c6662be09050b7baba9167d5ccb
    journal
    abbreviation
    J Clin Endocrinol Metab
    issn electronic
    Source null
    issn print
    0021-972X
    issue
    6
    name
    The Journal of clinical endocrinology and metabolism
    nlm unique id
    0375362
    pages
    2247-52
    volume
    85
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      10852458
      provenance
      batch id
      c98b220a79580c9840c7
      provider
      NCBI PubMed ESummary
      record sha256
      19c468fdb144c817749cec65d27466ccc601abf0c7ee9ce907c7821bb93a431c
      response sha256
      d5d875b1aa149faaecebc150cec3cacc2861402b103226e5006d2b0ce5dccd23
      retrieved at
      2026-09-09T23:45:37.924736+00:00
      publication date
      display
      2000 Jun
      precision
      month
      year
      2000
      publication types
      1. Clinical Trial
      2. Controlled Clinical Trial
      3. Journal Article
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/10852458/
      title
      Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients.

      Preserved source evidence · Not medical advice